search button
Open Access

[Corrigendum] WEE1 inhibition by MK1775 as a single‑agent therapy inhibits ovarian cancer viability

  • Authors:
    • Minghui Zhang
    • Donye Dominguez
    • Siqi Chen
    • Jie Fan
    • Lei Qin
    • Alan Long
    • Xia Li
    • Yi Zhang
    • Huirong Shi
    • Bin Zhang

  • View Affiliations

  • Published online on: May 21, 2018     https://doi.org/10.3892/ol.2018.8757
  • Pages: 1366-1366

  • Copyright : © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Oncol Lett 14: [Related article:] 3580-3586, 2017; DOI: 10.3892/ol.2017.6584

Following the publication of this article, an interested reader drew to our attention an error in the published text: On p. 3580, the first sentence of the Abstract should have read as “Wee1-like protein kinase (WEE1) physiologically serves a key function in maintaining the integrity of the cell genome through mediating the inactivation of cyclin-dependent kinase (CDK)1 and CDK2.” (i.e., “activation” was featured incorrectly).

Likewise, the first sentence in the Introduction should have read as “Wee1-like protein kinase (WEE1) … contributes to the upstream regulation of the cyclin-dependent kinase (CDK) complexes by mediating the inactivation of CDK1.”

We apologize that these errors were allowed to remain in the paper, and regret the inconvenience that this has caused.

Related Articles

Journal Cover

July-2018
Volume 16 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.9
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 6.3
  • CiteScore Rank: Q2: #119/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.725
  • SCImago Journal Rank (SJR): 0.639
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang M, Dominguez D, Chen S, Fan J, Qin L, Long A, Li X, Zhang Y, Shi H, Zhang B, Zhang B, et al: [Corrigendum] WEE1 inhibition by MK1775 as a single‑agent therapy inhibits ovarian cancer viability. Oncol Lett 16: 1366-1366, 2018
APA
Zhang, M., Dominguez, D., Chen, S., Fan, J., Qin, L., Long, A. ... Zhang, B. (2018). [Corrigendum] WEE1 inhibition by MK1775 as a single‑agent therapy inhibits ovarian cancer viability. Oncology Letters, 16, 1366-1366. https://doi.org/10.3892/ol.2018.8757
MLA
Zhang, M., Dominguez, D., Chen, S., Fan, J., Qin, L., Long, A., Li, X., Zhang, Y., Shi, H., Zhang, B."[Corrigendum] WEE1 inhibition by MK1775 as a single‑agent therapy inhibits ovarian cancer viability". Oncology Letters 16.1 (2018): 1366-1366.
Chicago
Zhang, M., Dominguez, D., Chen, S., Fan, J., Qin, L., Long, A., Li, X., Zhang, Y., Shi, H., Zhang, B."[Corrigendum] WEE1 inhibition by MK1775 as a single‑agent therapy inhibits ovarian cancer viability". Oncology Letters 16, no. 1 (2018): 1366-1366. https://doi.org/10.3892/ol.2018.8757